搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Treponema pallidum Uncharacterized protein TP_0352 (TP_0352) CSB-YP526919TPR
CSB-EP526919TPR
CSB-BP526919TPR
CSB-MP526919TPR
CSB-EP526919TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Uncharacterized protein TP_0368 (TP_0368), partial CSB-YP526920TPR
CSB-EP526920TPR
CSB-BP526920TPR
CSB-MP526920TPR
CSB-EP526920TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Uncharacterized protein TP_0374 (TP_0374), partial CSB-YP526921TPR
CSB-EP526921TPR
CSB-BP526921TPR
CSB-MP526921TPR
CSB-EP526921TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Protein translocase subunit SecA (secA), partial CSB-YP526922TPR
CSB-EP526922TPR
CSB-BP526922TPR
CSB-MP526922TPR
CSB-EP526922TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (murF) CSB-YP526923TPR
CSB-EP526923TPR
CSB-BP526923TPR
CSB-MP526923TPR
CSB-EP526923TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Flagellar assembly protein fliH (fliH) CSB-YP526924TPR
CSB-EP526924TPR
CSB-BP526924TPR
CSB-MP526924TPR
CSB-EP526924TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Protein translocase subunit SecF (secF), partial CSB-YP526925TPR1
CSB-EP526925TPR1
CSB-BP526925TPR1
CSB-MP526925TPR1
CSB-EP526925TPR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Apolipoprotein N-acyltransferase 2 (lnt2), partial CSB-YP526926TPR1
CSB-EP526926TPR1
CSB-BP526926TPR1
CSB-MP526926TPR1
CSB-EP526926TPR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum V-type ATP synthase subunit E (atpE) CSB-YP526927TPR
CSB-EP526927TPR
CSB-BP526927TPR
CSB-MP526927TPR
CSB-EP526927TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum V-type ATP synthase subunit D 1 (atpD1) CSB-YP526928TPR
CSB-EP526928TPR
CSB-BP526928TPR
CSB-MP526928TPR
CSB-EP526928TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Non-canonical purine NTP pyrophosphatase (TP_0438) CSB-YP526929TPR
CSB-EP526929TPR
CSB-BP526929TPR
CSB-MP526929TPR
CSB-EP526929TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Uncharacterized protein TP_0447 (TP_0447) CSB-YP526930TPR
CSB-EP526930TPR
CSB-BP526930TPR
CSB-MP526930TPR
CSB-EP526930TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Isoleucine--tRNA ligase (ileS), partial CSB-YP526931TPR
CSB-EP526931TPR
CSB-BP526931TPR
CSB-MP526931TPR
CSB-EP526931TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum tRNA (guanine-N (7)-)-methyltransferase CSB-YP526932TPR
CSB-EP526932TPR
CSB-BP526932TPR
CSB-MP526932TPR
CSB-EP526932TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Uncharacterized protein TP_0467 (TP_0467) CSB-YP526933TPR
CSB-EP526933TPR
CSB-BP526933TPR
CSB-MP526933TPR
CSB-EP526933TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Uncharacterized protein TP_0480 (TP_0480), partial CSB-YP526934TPR1
CSB-EP526934TPR1
CSB-BP526934TPR1
CSB-MP526934TPR1
CSB-EP526934TPR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Uncharacterized protein TP_0484 (TP_0484), partial CSB-YP526935TPR1
CSB-EP526935TPR1
CSB-BP526935TPR1
CSB-MP526935TPR1
CSB-EP526935TPR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Uncharacterized lipoprotein TP_0503 (TP_0503) CSB-YP526936TPR
CSB-EP526936TPR
CSB-BP526936TPR
CSB-MP526936TPR
CSB-EP526936TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Bifunctional enzyme IspD/IspF (ispDF) CSB-YP526937TPR
CSB-EP526937TPR
CSB-BP526937TPR
CSB-MP526937TPR
CSB-EP526937TPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema pallidum Uncharacterized protein TP_0522 (TP_0522), partial CSB-YP526938TPR1
CSB-EP526938TPR1
CSB-BP526938TPR1
CSB-MP526938TPR1
CSB-EP526938TPR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>